This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from
Merck Sharp & Dohme Corp.
Heart failure (HF) is a common condition that affects approximately
5.7 million people in the United States, and the prognosis for
patients with heart failure has traditionally been poor. Projections
show that by 2030, the prevalence of heart failure will increase 46
percent from recent estimates. HF is the reason for more than 1
million hospitalizations per year and an estimated $31 billion in
costs in the U.S. each year. Fortunately for patients with HF, new
and emerging therapeutic options have improved both clinical and
economic outcomes for these patients and the system.
Upon completion of this
activity, participants will be able to:
Characterize the disease burden of
HF in the managed care setting as determined by hospitalizations
and other components of morbidity and mortality
Analyze what managed care and payers
need to know about newer therapies in heart failure management
Examine the latest clinical evidence
regarding the safety and efficacy of sGC modulators for treating
patients with HF with reduced ejection fraction (HFrEF)
Discuss current economic and
logistic barriers to appropriate HF therapy in the managed care
Apply methods to enable optimal cost
management of newer heart failure therapy to be realized by
multiple heart failure stakeholders including managed care
||Gary Owens, MD
Gary Owens Associates
has no financial relationships with ineligible companies
MD has no financial relationships with ineligible
companies to disclose.
Jeremy Williams has no financial relationships with
ineligible companies to disclose.
Jacqueline Cole, RN, MS, CMCN has no financial
relationships with ineligible companies to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue